Health Care Facilities

Sonida Senior Living

Sonida Senior Living released FY2026 Q1 earnings on May 11 Pre-Market (EST), actual revenue USD 111.27 M (forecast USD 122.79 M), actual EPS USD -2.39 (forecast USD -1.5333)

Sonida Senior Living to Release FY2026 Q1 Earnings on May 11 Pre-Market EST, Forecast Revenue USD 122.79 M, EPS USD -1.5333

Sonida Senior Living Director Buys Shares

Sonida Senior Living released FY2025 Q4 earnings on March 11 Pre-Market (EST), actual revenue USD 87.35 M, actual EPS USD -1.7223 (forecast EPS USD -1.3)

Sonida Senior Living released FY2025 annual earnings on March 11 Pre-Market (EST), actual revenue USD 336.39 M (forecast USD 337.93 M), actual EPS USD -4.2249 (forecast USD -3.8)

Sonida Completes 1.8 Billion Dollar Merger with CNL

Sonida Senior Living to Release FY2025 Q4 Earnings on March 11, 2026, Pre-Market EST; Forecast EPS -1.3 USD

Sonida Senior Living released FY2025 Q3 earnings on November 10 Pre-Market EST, with actual revenue of USD 85.74 M and EPS of USD -1.5644

Sonida Senior Living released FY2025 9 Months Earnings on November 10 Pre-Market EST, with actual revenue of USD 249.04 M and EPS of USD -2.501

Sonida Senior Living to Release FY2025 Q3 Earnings on November 10, Pre-Market EST

Sonida Senior Living released FY2025 Q2 earnings on August 11 Pre-Market EST, actual revenue USD 82.98 M, actual EPS USD -0.1642

Sonida Senior Living released FY2025 Semi-Annual Earnings on August 11 Pre-Market EST, with actual revenue of USD 163.3 M and EPS of USD -0.94

Sonida Senior Living to Release FY2025 Q2 Earnings on August 11, Pre-Market EST

Sonida Holds Annual Shareholder Meeting to Elect New Directors

Sonida Completes Acquisition of Two Senior Living Communities

Brandon Ribar Acquires Shares of Sonida Senior Living Inc.

Morgan Stanley Maintains Sonida Senior Living's Rating and Adjusts Price Target

Sonida Senior Living released FY2025 Q1 earnings on May 12 Pre-Market EST, actual revenue USD 80.32 M, actual EPS USD -0.7723

Sonida Senior Living Reports Strong Q1 Results

Sonida Senior Living Announces Q1 Operating Expenses and Earnings Per Share

OPTIMI HEALTH CORP

Silexion Therapeutics

FLAG SHIP ACQUISITION CORPORATION COM USD0.001 (SUB/RIGHT 31/03/2026)

Micware

GCL Global

HCW Biologics

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

Jupiter Neurosciences

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

SNDA

Sonida Senior Living has launched a $250 million at-the-market equity program, allowing share sales on the NYSE through major banks. Commissions are capped at 2.0%. Proceeds will fund acquisitions, capital improvements, working capital, and potential debt repayment. The company has also executed forward sale master confirmations to enhance flexibility in equity issuance.

TradingView

ROYAL BANK OF CANADA

Bank of Montreal

Citigroup

Goldman Sachs

JPMorgan Chase

Morgan Stanley

Wells Fargo

Citizens Financial

KeyCorp

CITIGROUP INC 6.250 NON CUM SER II PFD WI

GS Hldg R

JPMORGAN CHASE & CO. 4.20% DEP SHS REPSTG 1/400TH PFD SER MM

JPMORGAN CHASE & CO. 6%NON CUM DEP SHS REP 1/400TH PFD SER EE

JPMORGAN CHASE & CO. DEP REP 1/400TH (5.75% NON CUM PFD DD)

JPMORGAN CHASE & CO. 4.625% DEP SH RE 1/400TH INT NO CU PF LL

JPMorgan Chase & Co.

JPMORGAN CHASE & CO. 4.55% DEP SHS REPSTG 1/400TH PFD SER JJ

JPMORGAN CHASE & CO. 4.75 DEP SHS REP 1/400 NCUM PFD SR GG

MORGAN STANLEY DEP SHS EA REP 1/1000 SHS NON CUM PFD O

MORGAN STANLEY DEP SHS REPSTG 1/1000TH PFD SER Q

MORGAN STANLEY DEP SHS REPS 1/1000 7.125% PFD E

MORGAN STANLEY NON-CUM DEP SH REP 1/1000 PFD SER I

MORGAN STANLEY 4.875 DEP SHS REP 1/1000 NCUM PFD SR L

MORGAN STANLEY 6.5%DEP SHS REPSTG 1/1000 NON CUM SER P

MORGAN STANLEY DEP SHS REPS 1/1000 PFD SER 'A'

MORGAN STANLEY DEP SHS REPR 1/1000TH INT PFD SER 'F' FX

MORGAN STANLEY DEP SHS REP 1/1000 NON-CUM PFD STK SER K

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A DD

WELLS FARGO & COMPANY 7.5% PERP CONV PRF CLS 'A' SERIES 'L'

WELLS FARGO & COMPANY DEP SHS REP 1/1000 INT PER PFD SER Y A

WELLS FARGO & COMPANY DP SHS REP 1/1000TH INT NCUM PFD CL A CC

WELLS FARGO & COMPANY 4.75% DEP SHS 1/1000 NCUM PFD CL A SR Z

WELLS FARGO & COMPANY DEP SHS REP 1/1000TH INT PFD SR AA (CLA)

CITIZENS FINANCIAL GROUP INC DEP SHS REPSTG 1/40TH PERP PFD SR I

CITIZENS FINANCIAL GROUP INC 5% DEP SHS EA REP 1/40TH NON CUM SER E

CITIZENS FINANCIAL GROUP INC DEP SHS REPSTG 1/40TH PERP PFD SER H

KEYCORP DEP SHS REP 1/40TH NON CUM PER PFD SER G

KEYCORP DEP SHS REPSTG 1/40TH INT PERP NON CUM H

KEYCORP DEP SHS REP 1/40TH PERP PFD SER F USD25

KEYCORP DEP SHS REP 1/40TH NON CUM PFD SER E

Sonida Senior Living Launches $250 Million At-The-Market Equity Program With Major Banks

Sonida Senior Living (SNDA) reported a Q1 2026 revenue of $111.3 million with a basic EPS loss of $2.39, worsening from a loss of $0.77 in Q1 2025. Despite revenue growth, net income loss increased to $61.4 million, raising concerns about profitability. The company's shares trade at a high P/S ratio of 4.7x, significantly above industry averages, while ongoing losses and shareholder dilution pose risks. Analysts warn that the combination of high valuation and persistent losses may challenge bullish narratives surrounding the company's growth prospects.

Simplywall

Sonida Senior Living (SNDA) Loss Worsening In Q1 2026 Challenges Bullish Scale Narratives

RBC Capital Markets stated that Sonida Senior Living's recent stock decline is unwarranted due to strong Q1 results. The company is experiencing margin expansion from effective cost controls and increased occupancy. RBC confirmed its outperform rating and raised the price target from $39 to $45 per share, while the stock is currently priced at $37.57, reflecting a 1.64% increase.

fidelity

Sonida Senior Living Stock Decline Unwarranted Given Business Momentum, RBC Says

Earnings Watch

Sonida Senior Living | 10-Q: FY2026 Q1 Revenue: USD 122.63 M

MRNA

ERAS

Healthcare stocks declined late Monday, with the NYSE Healthcare Index down 0.3% and the State Street Healthcare Select Sector SPDR ETF down 0.4%. Zoetis shares fell 7.5% after a price target cut by BNP Paribas. Moderna shares dropped 3.7% amid news of early-stage vaccine development. Sonida Senior Living reported a Q1 loss of $2.39 per share, leading to a 3.3% decline in shares. In contrast, Erasca shares rose 3% following a collaboration with Merck for a clinical trial.

Fidelity

Moderna

Zoetis

Merck

Erasca

iShares Global Healthcare

VG Health

Health Care Select Sector SPDR

iShares Biotechnology ETF

BNP Paribas

Factset Research

Sector Update: Healthcare Stocks Softer Late Afternoon

Healthcare stocks showed mixed performance on May 11, 2026, with the NYSE Healthcare Index up 0.2%. Moderna's shares fell 2.2% as it works on early-stage hantavirus vaccines. Sonida Senior Living reported a Q1 loss of $2.39 per share, leading to a 3.6% drop in its stock. In contrast, Erasca's shares rose 3.3% after announcing a collaboration with Merck for a clinical trial, while Merck's stock increased by 1.2%.

Invesco Biotechnology & Genome ETF

Fidelity MSCI Health Care Index

ALPS Medical Breakthrough

Proshares Ultra Nasdaq Biotech

First Trust NYSE Arca Biotech Index Fd

Direxion Healthcare Bull 3X

Direxion S&P Biotech Bull 3X

SPDR S&P Health Equip

VanEck Biotech ETF

SPDR S&P Health

Invesco Nasdaq Biotechnology ETF

iShares US Medical Devices

iShares US Pharma

SPDR S&P Biotech

Sector Update: Healthcare Stocks Mixed in Afternoon Trading

Sonida Senior Living Announces First Quarter 2026 Results | SNDA Stock News

StockTitan

Sonida Senior Living Announces First Quarter 2026 Results | SNDA Stock News

Sonida Senior Living, Inc (SNDA) reported a first-quarter loss of $61.390 million, or $2.39 per share, widening from a loss of $13.938 million, or $0.77 per share, in the previous year. However, the company's revenue increased by 33.4% to $122.632 million, up from $91.923 million last year. The earnings report highlights significant growth in revenue despite the increased losses.

nasdaq

Nasdaq

Sonida Senior Living, Inc Q1 Loss Widens

Sonida Senior Living (SNDA) has completed its acquisition of CNL Healthcare Properties for $1.8 billion, enhancing its portfolio with 69 senior housing communities. The Q1 2026 results show a 36.7% increase in resident revenue, although net loss widened to $41.2 million due to merger costs. Pro forma occupancy rose to 87.2%, with improved margins. To finance the acquisition, Sonida secured a $270 million bridge facility and $110 million from shareholders. Analysts rate SNDA as a Hold with a $37.00 price target, citing strong revenue growth but concerns over profitability and balance sheet risks.

Tip Ranks

Sonida Senior Living Closes CNL Acquisition, Reports Q1

Sonida Senior Living(SNDA.US)

Sonida Senior Living Launches $250 Million At-The-Market Equity Program With Major Banks

Sonida Senior Living (SNDA) Loss Worsening In Q1 2026 Challenges Bullish Scale Narratives

Sonida Senior Living Stock Decline Unwarranted Given Business Momentum, RBC Says

Sonida Senior Living | 10-Q: FY2026 Q1 Revenue: USD 122.63 M

Sector Update: Healthcare Stocks Softer Late Afternoon

Sector Update: Healthcare Stocks Mixed in Afternoon Trading

Sonida Senior Living Announces First Quarter 2026 Results | SNDA Stock News

Sonida Senior Living, Inc Q1 Loss Widens

Sonida Senior Living Closes CNL Acquisition, Reports Q1